Concepedia

Fernando Correa

FC

Statistics

Publications

25

Citations

1.8K

H-Index

20

Active since

2005

Affiliations

Instituto Cajal(Current)

Universidad de Buenos Aires

Inserm

Consejo Superior de Investigaciones Científicas

Serine Proteases and Pathophysiology of the neurovascular Unit

Fernando Correa is an author at Instituto Cajal specializing in cannabinoid pharmacology, neuroscience, and pharmacology.

ORCID

Publications per year

2005–2021

25

Publications

25

Anandamide enhances IL‐10 production in activated microglia by targeting CB<sub>2</sub>receptors: Roles of ERK1/2, JNK, and NF‐κB

Fernando Correa, Míriam Hernangómez, Leyre Mestre et al. · Glia · 2009 · 181 citations

, , +17

Pharmacological modulation of the endocannabinoid system in a viral model of multiple sclerosis

Leyre Mestre, Fernando Correa, Ángel Arévalo‐Martín et al. · Journal of Neurochemistry · 2005 · 134 citations

, , +17

Activation of cannabinoid CB<sub>2</sub> receptor negatively regulates IL‐12p40 production in murine macrophages: role of IL‐10 and ERK1/2 kinase signaling

Fernando Correa, Leyre Mestre, Fabián Docagne et al. · British Journal of Pharmacology · 2005 · 131 citations · Full text

, , +17

CD200‐CD200R1 interaction contributes to neuroprotective effects of anandamide on experimentally induced inflammation

Míriam Hernangómez, Leyre Mestre, Fernando Correa et al. · Glia · 2012 · 128 citations · Full text

, , +17

Activation of the endocannabinoid system as a therapeutic approach in a murine model of multiple sclerosis

Silvia Ortega‐Gutiérrez, Eduardo Molina‐Holgado, Ángel Arévalo‐Martín et al. · The FASEB Journal · 2005 · 121 citations

, , +17

1–5 of 25